Funding for this research was provided by:
National MS Society (MB-1606-08779)
Article History
Received: 10 December 2020
Revised: 13 May 2021
Accepted: 18 May 2021
First Online: 24 May 2021
Declarations
:
: Dr. John DeLuca received consulting fees/honorarium from Biogen, Sanofi—Genzyme, Novartis, Roche and Celgene. He has received grant funding from Biogen, EMD Serono, National Multiple Sclerosis Society (NMSS), Consortium of Multiple Sclerosis Centers (CMSC), and the National Institute of Health (NIH). Dr. Nancy Chiaravalloti received consulting fees/honorarium from Roche and Akili Interactive Labs. She has received grant funding from the NMSS, CMSC, and the NIH. Dr. Michelle Chen has received grant funding from the National Academy of Neuropsychology and the New Jersey Health Foundation.